Wungki Park, MD, MS
Gastrointestinal Medical Oncologist
My Role at MSKWe post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
Areas of Expertise
My Specialties
- Pancreatic Cancer
- Bile Duct Cancers/Cholangiocarcinoma
- Gall Bladder Cancers
About Me
- Assistant Attending Physician
I am a medical oncologist who specializes in caring for people with cancers of the pancreas, and bile system.
I am part of a team of experts from many different areas, including surgeons, radiation oncologists, gastroenterologists, interventional radiologists, and pathologists, to name a few. We work together to provide the best care for our patients and their families. I also partner with cancer biologists, immunologists, and bioinformaticians to identify and develop better treatments for our patients through clinical trials.
Read more
My research is focused on understanding how cancers do or do not respond to immunotherapy, which is treatment that involves using the body’s own immune system to attack cancer. In recent years, it has been incredibly exciting to see some patients have excellent responses to this type of treatment. Our mission is to develop new strategies so that more people with cancer can benefit from immunotherapy.
A gastrointestinal (GAS-troh-in-TES-tih-nul) medical oncologist is a cancer doctor who specializes in gastrointestinal (GI) cancers. This includes anal, colorectal, esophageal, gastric (stomach), liver, and pancreatic cancers, as well as GI stromal tumors and neuroendocrine tumors.
My Specialties
- Pancreatic Cancer
- Bile Duct Cancers/Cholangiocarcinoma
- Gall Bladder Cancers
- Developmental Therapeutics
- Immunotherapy
- Early-Phase Clinical Trials
Education
- MD, Yonsei University, Wonju College of Medicine
- MS, Clinical and Translational Cancer Research, The Gerstner Sloan Kettering Graduate School of Biomedical Sciences
Residencies
- Internal Medicine - Mount Sinai West-St. Luke's
Awards and Honors
- NIH-P50 Pancreas Specialized Program of Research Excellence (SPORE) Award RP2 (2022-2027)
- Break Through Cancer- Conquering KRAS Team Lab (2022-2025)
- Society of MSK Research Grant Award (2022-2023)
- The Best of the AACR Journals - Clinical Cancer Research article (2022)
- Rising Star Award, National Pancreas Foundation (2021)
- Parker Institute for Cancer Immunotherapy (PICI) MSKCC Pilot Grant Award (2019-2022)
- NIH-K12 Paul Calabresi Career Development Award for Clinical Oncology (2019-2022)
- ASCO Conquer Cancer Foundation Merit Award (2018)
- Society for Immunotherapy of Cancer (SITC) - Sparkathon (2017)
- Travel Award for AACR/ASCO Vail Workshop: Methods in Clinical Cancer Research (2016)
Fellowships
- Medical Oncology - University of Miami, Jackson Memorial Hospital
Board Certifications
- Internal Medicine
- Medical Oncology
Insurance Information
Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.
In Network Coverage Type
PPO
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
PPO, HMO, DSN
In Network Coverage Type
HMO, PPO
In Network Coverage Type
HMO, EPO PPO, POS
In Network Coverage Type
PPO, POS, EPO, HMO
Offers a qualified health plan from the Health Insurance Marketplace. Call Emblem to learn more.
In Network Coverage Type
PPO, HMO
In Network Coverage Type
PPO
In Network Coverage Type
HMO, EPO
Offers a qualified health plan from the Health Insurance Marketplace. Call Fidelis to learn more.
In Network Coverage Type
EPO, HMO, PPO, POS
Offers a qualified health plan from the Health Insurance Marketplace. Call Healthfirst to learn more.
In Network Coverage Type
HMO
In Network Coverage Type
PPO
In Network Coverage Type
EPO
In Network Coverage Type
EPO
In Network Coverage Type
Federal Government
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
State Government
Don't see your carrier or plan? We can help you understand your coverage.
If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.
If you have questions about insurance, call us at 646-497-9176.
Make an Appointment
Contact and Location
Dr. Park sees patients at one location.
Looking to see a doctor at a different location? See all MSK locations.
Colleagues
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
Clinical Trials
- Clinical Trials Investigated by Dr. Park
- A Phase 1 Study of ASP2138 in People With Pancreatic Cancer or Stomach or Gastroesophageal Junction Cancer That Makes Claudin (CLDN) 18.2
- A Phase 1/2 Study of AMG 193 Plus IDE397 to Treat Advanced Digestive Cancers Lacking the MTAP Protein
- A Phase I Study of ASP3082 in People with Solid Tumors with KRAS G12D Mutations
- A Phase I/II Study of MRG004A in People with Advanced Solid Tumors That Have the Tissue Factor Protein
Read more
- A Phase II Study of Olaparib in Patients with Advanced Biliary Tract Cancer
- Clinical Trials Co-Investigated by Dr. Park
- A Phase 1b Study of AMG 193 Plus mFOLFIRINOX or With Gemcitabine and Nab-paclitaxel in People With Advanced Pancreatic Cancer
- A Phase 2 Study of Nab-paclitaxel and Gemcitabine With or Without Botensilimab in People With Advanced Pancreatic Cancer
- A Phase I Study of RMC-6236 in People with Advanced Solid Tumors Containing Specific KRAS Mutations
- A Phase I Study of TJ033721 Immunotherapy in People with Advanced Pancreatic or Esophagogastric Cancer
- A Study of Glipizide to Treat High Blood Sugar in People With Pancreatic Cancer
Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Search clinical trialsResearch and Publications
Visit PubMed for a full listing of Dr. Park’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.
See all on PubMedPatient Reviews
Your trust is our main concern
We strive to keep reviews trustworthy, honest and fair. Learn more about our patient experience reviews.
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Wungki Park discloses the following relationships and financial interests:
-
American Physician Institute for Advanced Professional Studies LLC
Professional Services and Activities -
Astellas
Professional Services and Activities -
Break Through Cancer
Professional Services and Activities
-
EXACT Therapeutics AS
Professional Services and Activities -
Integrity Continuing Education, Inc.
Professional Services and Activities -
Revolution Medicines
Professional Services and Activities (Uncompensated)
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2023 through disclosure submission in spring 2024). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].